V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330002872 | 330001544 | 1.6 | 67.1 | Curative (C) | 2017-08-17 | 2017-09-02 | CARBOPLATIN | N | N | 330011694 | CARBOPLATIN |
| 330002873 | 330001544 | 1.62 | 80 | Disease modification (D) | 2013-10-04 | 2013-10-05 | Rituximab | 02 | null | 330011694 | RITUXIMAB |
| 330002874 | 330001544 | null | 66.2 | Not known (9) | 2014-07-23 | 2014-07-29 | Liposomal Doxorubicin 50mg/m2 | N | null | 330011694 | LIPOSOMAL DOXORUBICIN |
| 330002875 | 330001545 | 1.69 | 50.5 | Palliative (P) | 2015-02-17 | 2015-02-27 | CARBOPLATIN | N | N | 330011700 | CARBOPLATIN |
| 330002876 | 330001546 | 1.69 | 58.5 | Palliative (P) | 2015-08-31 | 2015-09-03 | Cisplatin + Doxorubicin | N | N | 330011701 | CISPLATIN + DOXORUBICIN |
| 330002877 | 330006822 | 1.57 | 50.2 | Palliative (P) | 2016-12-16 | 2016-12-18 | DOXORUBICIN | 2 | N | 330011703 | DOXORUBICIN |
| 330002879 | 330001548 | 1.75 | 81.8 | Curative (C) | 2015-11-09 | 2015-11-28 | Carboplatin AUC 6 - 10 | N | N | 330011707 | CARBOPLATIN |
| 330002880 | 330001548 | 1.7 | null | Curative (C) | 2013-11-25 | 2013-11-25 | CARBOPLATIN + ETOPOSIDE | N | N | 330011707 | CARBOPLATIN + ETOPOSIDE |
| 330002881 | 330001549 | 1.62 | 123.3 | Palliative (P) | 2016-11-24 | 2016-11-24 | Carboplatin AUC 2 - 5 | 02 | N | 330011711 | CARBOPLATIN |
| 330002882 | 330001550 | 1.68 | 91.2 | Curative (C) | 2015-02-12 | 2015-02-18 | BENDAMUSTINE + RITUXIMAB | N | N | 330011719 | BENDAMUSTINE + RITUXIMAB |
| 330002883 | 330001550 | 1.72 | null | Palliative (P) | 2013-06-02 | 2013-06-05 | Carboplatin + Paclitaxel (3 weekly) | 2 | N | 330011719 | CARBOPLATIN + PACLITAXEL |
| 330002884 | 330001550 | 1.74 | 88.35 | Adjuvant (A) | 2013-04-19 | 2013-04-19 | CARBOPLATIN | N | N | 330011719 | CARBOPLATIN |
| 330002885 | 330001551 | 1.65 | null | Palliative (P) | null | 2015-11-22 | Liposomal Doxorubicin (Caelyx) | N | N | 330011725 | LIPOSOMAL DOXORUBICIN |
| 330002886 | 330001551 | 1.83 | null | Palliative (P) | 2013-12-18 | 2013-12-18 | Carboplatin + Paclitaxel (weekly) | 2 | N | 330011725 | CARBOPLATIN + PACLITAXEL |
| 330002887 | 330001551 | 1.77 | 70.8 | Palliative (P) | 2017-09-11 | 2017-09-18 | Rituximab | N | N | 330011725 | RITUXIMAB |
| 330002888 | 330001552 | 1.85 | 66 | Neo-adjuvant (N) | 2014-08-27 | 2014-09-07 | Cisplatin + Doxorubicin | 02 | N | 330011730 | CISPLATIN + DOXORUBICIN |
| 330002889 | 330001553 | null | null | Palliative (P) | 2013-07-08 | 2013-07-19 | Carboplatin + Paclitaxel (3 weekly) | N | Y | 330011731 | CARBOPLATIN + PACLITAXEL |
| 330002890 | 330001554 | 1.8 | 96.4 | Curative (C) | 2016-05-28 | 2016-05-28 | Rituximab | 2 | N | 330011732 | RITUXIMAB |
| 330002891 | 330001555 | 1.73 | 52.3 | Curative (C) | 2014-01-21 | 2014-02-05 | CARBOPLATIN + ETOPOSIDE | N | Y | 330011734 | CARBOPLATIN + ETOPOSIDE |
| 330002892 | 330006826 | 1.56 | 5.6 | Palliative (P) | 2015-09-06 | 2015-09-06 | Carboplatin + Etoposide iv&po | N | N | 330011738 | CARBOPLATIN + ETOPOSIDE |
| 330002893 | 330001556 | 1.7 | 58 | Palliative (P) | null | 2015-06-17 | Carboplatin + Paclitaxel (3 weekly) | N | N | 330011739 | CARBOPLATIN + PACLITAXEL |
| 330002894 | 330001557 | null | 57 | Neo-adjuvant (N) | 2014-03-03 | 2014-03-06 | Cisplatin + Doxorubicin | N | N | 330011744 | CISPLATIN + DOXORUBICIN |
| 330002895 | 330001557 | 1.6 | 72.9 | Palliative (P) | 2014-07-25 | 2014-07-26 | Cisplatin + Doxorubicin | 2 | N | 330011744 | CISPLATIN + DOXORUBICIN |
| 330002896 | 330001558 | 1.7 | 81 | null | 2017-12-11 | 2017-12-12 | Rituximab | 02 | N | 330011747 | RITUXIMAB |
| 330002897 | 330001558 | 1.9 | 68.4 | Curative (C) | 2014-05-21 | 2014-05-23 | Rituximab | 02 | N | 330011747 | RITUXIMAB |
| 330002898 | 330009684 | 1.43 | 91.45 | Palliative (P) | 2016-04-01 | 2016-04-23 | Carboplatin + Paclitaxel (3 weekly) | N | N | 330011756 | CARBOPLATIN + PACLITAXEL |
| 330002899 | 330009684 | 1.68 | 70.8 | Curative (C) | 2016-09-28 | 2016-10-12 | Rituximab | N | N | 330011756 | RITUXIMAB |
| 330002900 | 330001559 | null | 76.4 | Disease modification (D) | null | 2017-01-17 | Rituximab | null | null | 330011759 | RITUXIMAB |
| 330002901 | 330006829 | 1.58 | 96.7 | Palliative (P) | 2015-02-01 | 2015-02-09 | DOXORUBICIN | Y | N | 330011761 | DOXORUBICIN |
| 330002902 | 330001560 | null | 84 | null | 2016-11-20 | 2016-11-28 | Carboplatin + Paclitaxel (3 weekly) | null | N | 330011762 | CARBOPLATIN + PACLITAXEL |
| 330002903 | 330001560 | 1.9 | 86 | Not known (9) | 2016-04-07 | 2016-04-24 | Liposomal Doxorubicin (Caelyx) | N | N | 330011762 | LIPOSOMAL DOXORUBICIN |
| 330002904 | 330001560 | 1.88 | 60 | Palliative (P) | 2017-07-08 | 2017-07-08 | Doxorubicin 75mg/m2 | 02 | N | 330011762 | DOXORUBICIN |
| 330002905 | 330001560 | 1.69 | null | Curative (C) | 2014-03-09 | 2014-03-09 | Carboplatin AUC 2 - 5 | N | N | 330011762 | CARBOPLATIN |
| 330002906 | 330001560 | 1.67 | 63.4 | Palliative (P) | 2016-12-03 | 2016-12-09 | Liposomal Doxorubicin (Caelyx) | 2 | N | 330011762 | LIPOSOMAL DOXORUBICIN |
| 330002907 | 330001561 | 1.85 | 69 | Palliative (P) | 2013-09-29 | 2013-10-13 | Carboplatin AUC 6 - 10 | N | N | 330011770 | CARBOPLATIN |
| 330002908 | 330006831 | 1.68 | 91 | Curative (C) | 2015-05-30 | 2015-05-30 | DOXORUBICIN | 02 | N | 330011771 | DOXORUBICIN |
| 330002909 | 330001562 | 1.89 | 55.6 | Not known (9) | 2013-05-12 | 2013-06-11 | Liposomal Doxorubicin (Caelyx) | N | N | 330011775 | LIPOSOMAL DOXORUBICIN |
| 330002910 | 330001562 | 1.68 | 60.4 | Neo-adjuvant (N) | 2016-09-01 | 2016-09-19 | Cisplatin + Doxorubicin | N | N | 330011775 | CISPLATIN + DOXORUBICIN |
| 330002911 | 330009686 | 1.86 | 76.45 | Palliative (P) | 2014-06-24 | 2014-06-26 | Carboplatin + Paclitaxel (3 weekly) | 2 | Y | 330011779 | CARBOPLATIN + PACLITAXEL |
| 330002912 | 330009686 | 1.55 | 71.3 | Palliative (P) | 2017-05-26 | 2017-06-17 | Carboplatin + Paclitaxel (3 weekly) | N | N | 330011779 | CARBOPLATIN + PACLITAXEL |
| 330002913 | 330001563 | 1.78 | 103 | Not known (9) | 2016-06-05 | 2016-06-08 | Carboplatin + Paclitaxel (3 weekly) | N | N | 330011781 | CARBOPLATIN + PACLITAXEL |
| 330002914 | 330001563 | 1.55 | 57.9 | Curative (C) | 2015-05-13 | 2015-05-27 | BENDAMUSTINE + RITUXIMAB | 02 | N | 330011781 | BENDAMUSTINE + RITUXIMAB |
| 330002915 | 330001563 | 1.41 | 52.9 | Curative (C) | 2016-10-26 | 2016-10-26 | Carboplatin + Etoposide IV 3 day | N | N | 330011781 | CARBOPLATIN + ETOPOSIDE |
| 330002916 | 330001564 | null | 55.8 | Disease modification (D) | 2015-08-06 | 2015-08-06 | BENDAMUSTINE + RITUXIMAB | 02 | N | 330011784 | BENDAMUSTINE + RITUXIMAB |
| 330002917 | 330001564 | 1.67 | 50 | Not known (9) | 2015-12-15 | 2016-01-01 | Bendamustine+Rituximab (1st Course) | 02 | N | 330011784 | BENDAMUSTINE + RITUXIMAB |
| 330002918 | 330001565 | 1.7 | 69 | Curative (C) | 2014-04-25 | 2014-05-06 | CARBOPLATIN + ETOPOSIDE | 2 | N | 330011786 | CARBOPLATIN + ETOPOSIDE |
| 330002919 | 330001565 | 1.8 | 86 | Palliative (P) | 2014-12-01 | 2014-12-17 | Bendamustine+Rituximab(Sub Courses) | 02 | Y | 330011786 | BENDAMUSTINE + RITUXIMAB |
| 330002920 | 330001565 | 1.78 | 78.6 | Curative (C) | 2014-09-29 | 2014-09-29 | Rituximab (Maintenance) | 02 | N | 330011786 | RITUXIMAB |
| 330002921 | 330001565 | 1.58 | 85.8 | Palliative (P) | 2014-10-02 | 2014-10-02 | CARBOPLATIN + PACLITAXEL | 02 | Y | 330011786 | CARBOPLATIN + PACLITAXEL |
| 330002922 | 330001565 | 1.6 | 67.1 | Palliative (P) | 2016-05-20 | 2016-05-28 | Carboplatin + Paclitaxel (3 weekly) | N | N | 330011786 | CARBOPLATIN + PACLITAXEL |